Physician profile
Denise Capps
NPI 1083061717
$2,232.87
in general payments reported to CMS, 2019-2025
10 companies · $940 in 2025
The $940 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.99 · 2020: $26.37 · 2021: $113 · 2022: $503 · 2023: $311 · 2024: $300 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,551.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,110.60 | 2019-2025 | Argos, Rocklatan, Clareon |
| Glaukos Corporation | $492.85 | 2020-2025 | Idosetr, Istent Infinite |
| Abbvie INC. | $349.06 | 2023-2025 | Xen Glaucoma Treatment System |
| Johnson & Johnson Surgical Vision, INC. | $109.18 | 2021-2025 | |
| Sight Sciences, INC. | $56.62 | 2023-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb Americas INC. | $24.65 | 2025 | Vyzulta, Miebo |
| Sun Pharmaceutical Industries INC. | $24.20 | 2025 | |
| Allergan, INC. | $23.01 | 2021 | |
| Biotissue Holdings INC. | $22.08 | 2022 | |
| Rxsight INC | $20.62 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Capps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.